TR-14035
A potent, orally bioavailable, dual α4β7/α4β1 integrin antagonist with IC50 of 7/87 nM; blocks the binding of human α4β7 to an (125) I-MAdCAM-Ig fusion protein with IC50 of 0.75 nM; suppresses antigen-induced lung interleukin (IL) -5 mRNA upregulation, inhibits the leukocyte rolling flux, adhesion and emigration induced by IL4 in rats.Asthma Phase 1 Discontinued.
Product Specifications
CAS Number
232271-19-1
Product Name Alternative
TR 14035 | TR14035
Purity
>98% (HPLC)
Solubility
DMSO:≥ 41 mg/mL
Smiles
O=C (O) [C@H] (CC1=CC=C (C2=C (OC) C=CC=C2OC) C=C1) NC (C3=C (Cl) C=CC=C3Cl) =O
Molecular Formula
C24H21Cl2NO5
Molecular Weight
474.3333
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
[1,1'-Biphenyl]-4-propanoic acid, α-[ (2,6-dichlorobenzoyl) amino]-2',6'-dimethoxy-, (αS) -
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6445198-01 0.1 mL
BAP1 (BRCA1 Associated Protein-1 (Ubiquitin Carboxy-Terminal Hydrolase), UCHL2, HUCEP-6, HUCEP-13) (HRP).
Sign In for Pricing
View Details MBS6445198-02 5x 0.1 mL
BAP1 (BRCA1 Associated Protein-1 (Ubiquitin Carboxy-Terminal Hydrolase), UCHL2, HUCEP-6, HUCEP-13) (HRP).
Sign In for Pricing
View Details